Biochemistry
-
Glycosaminoglycans induce conformational change in the SARS-CoV-2 Spike S1 Receptor Binding Domain
This article has 17 authors:Reviewed by ScreenIT
-
Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin
This article has 23 authors:Reviewed by ScreenIT
-
The crystal structure of nsp10-nsp16 heterodimer from SARS-CoV-2 in complex with S-adenosylmethionine
This article has 14 authors:Reviewed by ScreenIT
-
Sybodies targeting the SARS-CoV-2 receptor-binding domain
This article has 13 authors:Reviewed by ScreenIT
-
Protein structure analysis of the interactions between SARS-CoV-2 spike protein and the human ACE2 receptor: from conformational changes to novel neutralizing antibodies
This article has 5 authors:Reviewed by ScreenIT
-
Glycosaminoglycan binding motif at S1/S2 proteolytic cleavage site on spike glycoprotein may facilitate novel coronavirus (SARS-CoV-2) host cell entry
This article has 11 authors:Reviewed by ScreenIT
-
De novo 3D models of SARS-CoV-2 RNA elements and small-molecule-binding RNAs to aid drug discovery
This article has 9 authors:Reviewed by ScreenIT
-
Structural interactions between pandemic SARS-CoV-2 spike glycoprotein and human Furin protease
This article has 1 author:Reviewed by ScreenIT
-
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug Carmofur
This article has 21 authors:Reviewed by ScreenIT
-
Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity – opportunity for repurposed chemotherapy of COVID-19 infection
This article has 7 authors:Reviewed by ScreenIT